Skip to content Skip to footer
Subscribe Now

TOP 20

Biopharma M&A Top 20 2023
Top 20 Biopharma M&A of 2023 by Total Deal Value
Shots:With stringent antitrust regulation clasping the overall volume of M&A deals, the biopharma industry manages to hold up a few strong M&A while conquering the waves of unexpected economic turmoil in 2023In 2023, the global biopharma industry witnessed an astounding transformation with M&A deals. Pfizer’s acquisition of Seagen for $43B ranks first in…
January 24, 2024
Animal Health Based Top 20 2022
Top 20 Animal Health Companies Based on 2022 Total Revenue
Shots:The animal health industry is involved in a wide variety of services, from disease prevention to addressing insatiable nutritional needs. This sector not only protects us from potential zoonotic diseases but also delivers food of high quality derived from animalsIn 2022, the animal health industry was valued at $58.66B. By 2030, the global animal health…
December 14, 2023
Contract Development and Manufacturing Organizations Top 20 2022
20 Contract Development and Manufacturing Organizations (CDMOs) of 2022
Shots:Over the years, CDMOs have significantly transformed the course of pharmaceutical and biopharmaceutical companies by leveraging their flexible manufacturing facilities and on-time drug deliveriesCDMOs help meet the ever-evolving needs of the healthcare sector by fostering the use of new-age technologies and advanced drug development and manufacturing processesPharmaShots brings a condensed report on 20 Contract…
December 5, 2023
Prescription Drugs Based Top 20 2022
Top 20 Prescription Drugs Based on 2022 Total Revenue
Shots:Prescription drugs have an instrumental role in effectively controlling chronic diseases like heart-related conditions, diabetes, arthritis, hypertension, and cancer, among others. Unlike over-the-counter drugs, prescription drugs are advised not to be taken without the authorization of a doctorIn 2022, the global market size of prescription drugs was worth $1035.5B and is envisioned to…
November 21, 2023
Countries in Healthcare Innovation Top 20 2022
Top 20 Countries in Healthcare Innovation
Shots: PharmaShots unravels the determinants of healthcare innovation with this rigorously prepared report on the Top 20 Countries in Healthcare Innovation. A meticulous report that encompasses all the significant aspects, necessary for well-rounded and innovative growth in the healthcare industry for a country By deploying extensive market research, PharmaShots gathered, evaluated, organized, and analyzed the…
October 31, 2023
Generics Pharma Top 20 2021
Top 20 Generics Pharma Companies Based on 2022 Revenue
Shots: Safe, reliable, efficacious, and most importantly cost-effective, it won’t be wrong to ascribe generic drugs as the advocate for health equity. Generic drugs have indispensably aided the healthcare needs of developing and under-developed countries In 2022, the global market size of generic drugs was valued at $411.99B and is envisioned to reach $613.34B by…
October 11, 2023
Top 20 Monoclonal Antibodies Based on 2022 Total Revenue 
Shots:Monoclonal antibodies are transforming therapeutics through their highly efficient targeting mechanisms. There is a wide range of uses for monoclonal antibodies, including diagnosis, therapy, and researchIn 2021, the monoclonal antibody therapy market size was valued at $178.5B and is envisioned to reach $451.89B by 2028, displaying a CAGR of 14.1%. Humira was the…
September 26, 2023
Oncology Companies Based Top 20 2022
Top 20 Oncology Companies Based on 2022 By Total Revenue
Shots:With more than 50% of ongoing clinical trials worldwide in oncology domains, cancer remains one of the leading causes of death worldwide. Oncology companies are steadfastly looking for innovative therapies to cure both hematologic and solid tumor cancerThe global oncology drug market size in 2022 was valued at $185B and is forecasted to…
September 13, 2023
Companies Spending on R&D Top 20 2022
Top 20 Companies Spending on R&D in 2022
Shots:R&D (Research and Development) in the biopharma industry lays the foundation stone of innovative drugs. A robust R&D bolstered with new-age technological advances assures long-term sustainability in the future marketWith a global expenditure of $238B in 2022, the figures are anticipated to reach $285B by 2028. In 2022, AbbVie ranked the top among…
August 22, 2023
Immunology Based Top 20 2022
Top 20 Immunology Companies Based on 2022 Immunology Segment Total Revenue
Shots:With the noble responsibility of ensuring a healthy society on their shoulders, biopharma companies focused on Immunology are diligently working to develop treatments, vaccines, antibodies, and drugsThe global Immunology market was valued at $97.93B in 2021 and is anticipated to reach $184.21B by 2029 with a CAGR of 8.5 percent. In 2022, AbbVie…
August 14, 2023
Load more